A Multifunctional Lipid Incorporating Active Targeting and Dual-Control Release Capabilities for Precision Drug Delivery
- 27 November 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 12 (1) , 70-85
Abstract
Active targeting and precise control of drug release based on nanoparticle-based therapies are urgently required to precisely treat cancer. We have custom synthesized a functional lipid (termed Fa-ONB) by introducing a folic acid targeting group into an o-nitro-benzyl ester lipid. As designed, the liposomes formed by Fa-ONB combine active targeting and dual trigger release capabilities, which help to improve drug efficacy and reduce the toxicity of traditional liposomes. We first verified that both pH-induced hydrolysis and light treatment were able to cleave Fa-ONB lipid. We then prepared a series of liposomes (termed FOBD liposomes) by compounding the Fa-ONB lipid with DOPC at different ratios. After encapsulation of doxorubicin (DOX), we found that the particle size of DOX-loaded FOBD liposomes (DOX/FOBD) first increased (290 nm to 700 nm) and then decreased again (to 400 nm) under continuous UV irradiation (120 min). The photocatalytic release efficiency under different pH conditions was investigated by dialysis experiments, and it was found that the release efficiency in an acidic environment was significantly increased relative to neutral pH. This pH-triggered release response helps distinguish pathological tissues such as lysosomal compartments and tumors. The light-induced formation of a DOX precipitate increases in efficiency with increasing UV exposure time as well as with increasing environmental acidity or alkalinity. In addition, confocal imaging and flow cytometry showed that the ability of FOBD lipids to actively target HeLa cells increased with increasing Fa-ONB lipid content. Real-time in vivo fluorescence small animal experiments proved targeting to tumors and pH- and photo-induced release properties. Furthermore, therapeutic experiments using a mouse model found significant tumor inhibitory effect for DOX/FOBD55 liposomes with UV irradiation, clearly demonstrating the benefit of light treatment: the tumor size of the control (PBS) group was 7.59 times that of the light treatment group. Therefore, this research demonstrates the benefits of combining triggerable release functions and effective active tumor targeting in one small lipid molecule for precise cancer treatment.Keywords
Funding Information
- Ministry of Education of the People's Republic of China (DUT19GJ203)
- Ministry of Science and Technology of the People's Republic of China (2015DFA41670)
- China Scholarship Council ([2019]13044)
- Materials Research Laboratory, University of California Santa Barbara
- Chemical Analysis and Research Center for fluorescence imaging, Dalian University of Technology
This publication has 74 references indexed in Scilit:
- Nanotechnology Toward Treating Cancer2019
- Nano based drug delivery systems: recent developments and future prospectsJournal of Nanobiotechnology, 2018
- Progress and challenges towards targeted delivery of cancer therapeuticsNature Communications, 2018
- Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?Frontiers in Pharmacology, 2018
- Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biologyAdvanced Drug Delivery Reviews, 2014
- Passive and Active Tumour Targeting with NanocarriersCurrent Drug Discovery Technologies, 2011
- To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug deliveryJournal of Controlled Release, 2010
- Strategies in the design of nanoparticles for therapeutic applicationsNature Reviews Drug Discovery, 2010
- Nanocarriers as an emerging platform for cancer therapyNature Nanotechnology, 2007
- Targeted nanoparticles for cancer therapyNano Today, 2007